SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CONTOLI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.686
EU - Europa 2.188
AS - Asia 1.359
OC - Oceania 14
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 2
Totale 12.262
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.680
CN - Cina 726
IT - Italia 668
UA - Ucraina 448
TR - Turchia 283
DE - Germania 252
SG - Singapore 236
GB - Regno Unito 218
SE - Svezia 208
PL - Polonia 147
FI - Finlandia 117
ID - Indonesia 60
FR - Francia 55
CZ - Repubblica Ceca 19
VN - Vietnam 18
BE - Belgio 17
AU - Australia 11
IN - India 10
HK - Hong Kong 8
JP - Giappone 7
NL - Olanda 7
BR - Brasile 5
CA - Canada 5
ES - Italia 5
EU - Europa 4
HU - Ungheria 4
IR - Iran 4
MK - Macedonia 4
RU - Federazione Russa 4
NZ - Nuova Zelanda 3
RO - Romania 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
IE - Irlanda 2
PT - Portogallo 2
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
PK - Pakistan 1
RS - Serbia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 12.262
Salva come PNG Salva come JPEG
Città #
Fairfield 1.248
Woodbridge 1.044
Houston 956
Ashburn 601
Jacksonville 556
Chandler 537
Ann Arbor 507
Wilmington 488
Seattle 483
Cambridge 426
Izmir 186
Nanjing 176
Princeton 169
Ferrara 156
Warsaw 145
Singapore 141
Beijing 120
Milan 114
New York 103
San Diego 103
Boardman 89
Shanghai 82
Addison 64
Jakarta 60
Los Angeles 58
Dearborn 55
Nanchang 49
Shenyang 47
Mountain View 35
Washington 35
Changsha 30
Hebei 30
Tianjin 30
Jiaxing 29
Redwood City 28
Falls Church 26
Bologna 22
Norwalk 22
Jinan 21
Bremen 19
London 19
Orange 18
Brussels 17
Dong Ket 16
Kunming 16
Brno 15
Rome 14
Taizhou 13
Des Moines 12
Auburn Hills 11
Zhengzhou 11
Augusta 10
Guangzhou 10
Ningbo 10
San Mateo 10
Chicago 9
Helsinki 9
Lappeenranta 9
Ferrara di Monte Baldo 8
Lanzhou 8
Paris 8
Redmond 8
Verona 8
Council Bluffs 7
Parma 7
Catania 6
Hefei 6
Hong Kong 6
Indiana 6
Istanbul 6
Napoli 6
Philadelphia 6
Reggio Nell'emilia 6
Tappahannock 6
Vicenza 6
Changchun 5
Kilburn 5
Budapest 4
Frankfurt am Main 4
Hounslow 4
Islington 4
Leawood 4
Lecco 4
Monmouth Junction 4
Olomouc 4
Padova 4
Palermo 4
Tokyo 4
Albano 3
Bari 3
Bozzolo 3
Chiswick 3
Detroit 3
Florence 3
Modena 3
Oristano 3
Rimini 3
Akita 2
Albignasego 2
Ardabil 2
Totale 9.520
Salva come PNG Salva come JPEG
Nome #
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 296
The contribution of small-Airway abnormalities in chronic obstructive pulmonary disease clinical manifestations: More than a functional issue 187
Respiratory muscle training with normocapnic hyperpnea improves ventilatory pattern and thoracoabdominal coordination, and reduces oxygen desaturation during endurance exercise testing in COPD patients 186
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 183
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 167
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 154
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 153
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 138
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 133
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 132
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 132
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 131
Models of infection and exacerbations in COPD. 130
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 128
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 126
null 126
Rhinovirus vaccination: the case against 124
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 124
null 121
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 119
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 118
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 118
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 116
null 114
Physiologic Evaluation of Ventilation Perfusion Mismatch and Respiratory Mechanics at Different Positive End-expiratory Pressure in Patients Undergoing Protective One-lung Ventilation 113
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 112
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production 111
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 111
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma. 109
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 107
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 107
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 106
Morte per asma. Parte I: fenotipi clinici, epidemiologia e fattori di rischio. 105
Reducing Agents Decrease the Oxidative Burst and Improve Clinical Outcomes in COPD Patients: A Randomised Controlled Trial on the Effects of Sulphurous Thermal Water Inhalation. 105
Oxidants in asthma and in chronic obstructive pulmonary disease (COPD) 104
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. 104
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. 103
null 102
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations. 102
IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma 101
Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia 98
Small airway disease in asthma: pathophysiological and diagnostic considerations 98
When asthma diagnosis becomes a challenge 97
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 97
Xanthine oxidase activation by HRV16 infection in respiratory epithelial cells 95
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 95
γδT cells suppress inflammation and disease during rhinovirus-induced asthma exacerbations. 95
Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease. 94
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 94
Mechanisms of respiratory virus-induced asthma exacerbations 92
ELEMENTI DI VALUTAZIONE E DIAGNOSTICA FUNZIONALE DELL’APPARATO RESPIRATORIO 92
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 92
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 92
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 91
Interleukin-4 Modulates Rhinovirus Replication and Antiviral Immune Response in Respiratory Epithelial Cells 91
Increased deposition of activated complement in peripheral lung vessels of smokers 91
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 91
Targeting Th2 cells in asthmatic airways 90
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 90
null 90
Models of respiratory infections: Virus-induced asthma exacerbations and beyond 90
Rhinovirus-induced bronchial mucosal inflammatory response in asthma 89
Neutrophil adhesion molecules in experimental rhinovirus infection in COPD. 88
null 88
Anti-SARS-Cov-2 IgA response in tears of COVID-19 patients 88
Symptom variability and control in COPD: Advantages of dual bronchodilation therapy 87
null 87
Rhinovirus-induced interferon production in asthma 85
Is Peripheral Oxygen Saturation a Reliable Predictor of Upper Airways Air-Flow Limitation? 84
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 84
null 83
Bronchial epithelial cells from asthmatic children have a deficient innate immune response to rhinovirus infection 83
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 83
Do small airway abnormalities characterize asthma phenotypes? In search of proof. 82
Effects of aclidinium on determinants of COPD severity: Symptoms and quality of life 81
Cellule staminali e patologia polmonare dell’adulto 80
Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine 79
Effects of Anti-IL-5 on Virus-induced Exacerbation in Asthma Light and Shadow 79
A simple method for home exercise training in patients with chronic obstructive pulmonary disease: One-year study 78
The small airways and distal lung compartment in asthma and COPD: A time for reappraisal 77
Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease 77
Interactions of airway pathogens and inflammatory processes 76
Deficient immune response to viral infections in children predicts later Asthma persistence 75
Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up 75
Pathophysiology of viral-induced exacerbations of COPD 74
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 74
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 73
Asthma: A Chronic Infectious Disease? 73
null 71
Update in asthma 2016 71
Interactions of airway pathogens and inflammatory processes 71
Midazolam in flexible bronchoscopy premedication: effects on patient-related and procedure-related outcomes. 70
null 70
Role of deficient type III interferon-lambda production in asthma exacerbations 68
Disease awareness in patients with COPD: measurement and extent 68
null 66
Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD 65
Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations 64
Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study 63
Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study 62
Totale 10.104
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.888
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.987
Totale 67.875
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.477 0 0 93 389 237 526 282 294 246 249 86 75
2020/20212.212 126 132 170 247 155 181 103 261 74 305 266 192
2021/20221.529 74 125 108 140 56 80 85 98 65 116 160 422
2022/20231.438 185 62 69 145 205 192 107 117 174 26 104 52
2023/2024980 74 107 48 29 59 170 38 68 34 34 49 270
2024/2025216 100 107 9 0 0 0 0 0 0 0 0 0
Totale 12.639